BTRX-246040 Completed Phase 2 Trials for Motor Skills Disorders / Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03608371BTRX-246040 Study in Subjects With Parkinson's Disease With Motor Fluctuations